We are live on ! Find out more
NBTX

Nanobiotix
NBTX

9 hedge funds and large institutions have $39.1M invested in Nanobiotix in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

121% more capital invested

Capital invested by funds: $17.7M → $39.1M (+$21.4M)

80% more funds holding

Funds holding: 5 → 9 (+4)

2.88% more ownership

Funds ownership: 9.94% → 12.82% (+2.9%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JJ
Johnson & Johnson
New Jersey
+$7.96M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$4.45M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$92.9K
4
Morgan Stanley
Morgan Stanley
New York
+$14.1K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$5.81K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.19M
2
UBS Group
UBS Group
Switzerland
-$1.63K
3
JP Morgan Chase
JP Morgan Chase
New York
-$10

NBTX Hedge Fund Activity: Q3 2023 in Review

9 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2023, worth a combined $39.1M — up 121% from $17.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NBTX positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Johnson & Johnson, opening a new position worth an estimated $7.96M. The largest seller was Perceptive Advisors, cutting an estimated $4.19M.

  • 9 institutional investors held Nanobiotix (NBTX) as of Q3 2023, up from 5 in Q2 2023.
  • Funds reported $39.1M of Nanobiotix stock for Q3 2023, up 121% quarter-over-quarter.
  • 5 funds opened new Nanobiotix positions in Q3 2023 and 1 closed out, a net change of +4 holders.
  • The largest Nanobiotix buyer in Q3 2023 was Johnson & Johnson, an estimated $7.96M added.
  • The largest Nanobiotix seller in Q3 2023 was Perceptive Advisors, an estimated $4.19M sold.

Based on aggregated 13F filings for Q3 2023.